Interstitial Lung Disease trials recruiting in Florida

All Interstitial Lung Disease trials nationally

Cities in Florida

Recruiting trials in Florida

• A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
  NCT07816185 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · Florida: Kissimmee
• An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
  NCT07234032 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Naples
• An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
  NCT06129240 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · Florida: Orlando, Tampa
• DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
  NCT06388421 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Florida: Gainesville, Naples, Orlando, Sarasota
• Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
  NCT07179380 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Gainesville, Naples, St. Petersburg